Unconventional human T cells accumulate at the site of infection in response to microbial ligands and induce local tissue remodeling

Journal of Immunology

Volumn 197, Issue 6, 2016, Pages 2195-2207

  Liuzzi, Anna Rita ^a   Kift Morgan, Ann ^a   Lopez Anton, Melisa ^a,b   Friberg, Ida M ^a,g   Zhang, Jingjing ^a   Brook, Amy C ^a   Roberts, Gareth W ^b,c   Donovan, Kieron L ^b,c   Colmont, Chantal S ^b   Toleman, Mark A ^a   Bowen, Timothy ^a,b   Johnson, David W ^d,e,f   Topley, Nicholas ^a   Moser, Bernhard ^a   Fraser, Donald J ^a,b,c   Eberl, Matthias ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Heath Park   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e TRANSLATIONAL RESEARCH INSTITUTE   (Australia)

^f Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry   (Australia)

^g UNIVERSITY OF SALFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHYL BUT 2 ENYL PYROPHOSPHATE; GAMMA INTERFERON; PYROPHOSPHORIC ACID DERIVATIVE; RIBOFLAVIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; LIGAND;

ADULT; ARTICLE; BACTERIAL INFECTION; BACTERIAL PERITONITIS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; GENERAL PATHOLOGICAL PARAMETERS; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INFLAMMATION; LOCAL TISSUE REMODELING; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; MAJOR CLINICAL STUDY; NONHUMAN; PATIENT MONITORING; PERITONEAL CAVITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; VITAMIN METABOLISM; BIOSYNTHESIS; CELL MOTION; EPITHELIAL MESENCHYMAL TRANSITION; IMMUNOLOGY; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PERITONITIS; PHYSIOLOGY;

BACTERIAL INFECTIONS; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; INTERFERON-GAMMA; LIGANDS; NEUTROPHIL INFILTRATION; PERITONITIS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84988965748     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600990     Document Type: Article

References (45)

1. Godfrey, D. I., A. P. Uldrich, J. McCluskey, J. Rossjohn, and D. B. Moody. 2015. The burgeoning family of unconventional T cells. Nat. Immunol. 16: 1114-1123.
2. Fan, X., and A. Y. Rudensky. 2016. Hallmarks of tissue-resident lymphocytes. Cell 164: 1198-1211.
3. Bonneville, M., R. L. O'Brien, and W. K. Born. 2010. gdT cell effector functions: a blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 10: 467-478.
4. Vantourout, P., and A. Hayday. 2013. Six-of-The-best: unique contributions of gd T cells to immunology. Nat. Rev. Immunol. 13: 88-100.
5. Gold, M. C., and D. M. Lewinsohn. 2013. Co-dependents: MR1-restricted MAIT cells and their antimicrobial function. Nat. Rev. Microbiol. 11: 14-19.
6. Adams, E. J. 2014. Lipid presentation by human CD1 molecules and the diverse T cell populations that respond to them. Curr. Opin. Immunol. 26: 1-6.
7. McEwen-Smith, R. M., M. Salio, and V. Cerundolo. 2015. CD1d-dependent endogenous and exogenous lipid antigen presentation. Curr. Opin. Immunol. 34: 116-125.
8. Van Rhijn, I., and D. B. Moody. 2015. Donor unrestricted T cells: a shared human T cell response. J. Immunol. 195: 1927-1932.
9. Liuzzi, A. R., J. E. McLaren, D. A. Price, and M. Eberl. 2015. Early innate responses to pathogens: pattern recognition by unconventional human T-cells. Curr. Opin. Immunol. 36: 31-37.
10. Davey, M. S., M. P. Morgan, A. R. Liuzzi, C. J. Tyler, M. W. Khan, T. Szakmany, J. E. Hall, B. Moser, and M. Eberl. 2014. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J. Immunol. 193: 3704-3716.
11. Tyler, C. J., D. G. Doherty, B. Moser, and M. Eberl. 2015. Human Vg9/Vd2 T cells: innate adaptors of the immune system. Cell. Immunol. 296: 10-21.
12. Rhodes, D. A., W. Reith, and J. Trowsdale. 2016. Regulation of immunity by butyrophilins. Annu. Rev. Immunol. 34: 151-172.
13. Eberl, M., G. W. Roberts, S. Meuter, J. D. Williams, N. Topley, and B. Moser. 2009. A rapid crosstalk of human gdT cells and monocytes drives the acute inflammation in bacterial infections. PLoS Pathog. 5: e1000308.
14. Davey, M. S., C. Y. Lin, G. W. Roberts, S. Heuston, A. C. Brown, J. A. Chess, M. A. Toleman, C. G. Gahan, C. Hill, T. Parish, et al. 2011. Human neutrophil clearance of bacterial pathogens triggers anti-microbial gd T cell responses in early infection. PLoS Pathog. 7: e1002040.
15. Lin, C. Y., G. W. Roberts, A. Kift-Morgan, K. L. Donovan, N. Topley, and M. Eberl. 2013. Pathogen-specific local immune fingerprints diagnose bacterial infection in peritoneal dialysis patients. J. Am. Soc. Nephrol. 24: 2002-2009.
16. Kjer-Nielsen, L., O. Patel, A. J. Corbett, J. Le Nours, B. Meehan, L. Liu, M. Bhati, Z. Chen, L. Kostenko, R. Reantragoon, et al. 2012. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491: 717-723.
17. Topley, N., A. Jörres, W. Luttmann, M. M. Petersen, M. J. Lang, K. H. Thierauch, C. Müller, G. A. Coles, M. Davies, and J. D. Williams. 1993. Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1b and TNF a. Kidney Int. 43: 226-233.
18. Beavis, M. J., J. D. Williams, J. Hoppe, and N. Topley. 1997. Human peritoneal fibroblast proliferation in 3-dimensional culture: modulation by cytokines, growth factors and peritoneal dialysis effluent. Kidney Int. 51: 205-215.
19. Lin, C. Y., A. Kift-Morgan, B. Moser, N. Topley, and M. Eberl. 2013. Suppression of pro-inflammatory T-cell responses by human mesothelial cells. Nephrol. Dial. Transplant. 28: 1743-1750.
20. Morita, C. T., H. Li, J. G. Lamphear, R. R. Rich, J. D. Fraser, R. A. Mariuzza, and H. K. Lee. 2001. Superantigen recognition by gammadelta T cells: SEA recognition site for human Vg2 T cell receptors. Immunity 14: 331-344.
21. van Diepen, A. T., S. van Esch, D. G. Struijk, and R. T. Krediet. 2015. The first peritonitis episode alters the natural course of peritoneal membrane characteristics in peritoneal dialysis patients. Perit. Dial. Int. 35: 324-332.
22. Fielding, C. A., G. W. Jones, R. M. McLoughlin, L. McLeod, V. J. Hammond, J. Uceda, A. S. Williams, M. Lambie, T. L. Foster, C. T. Liao, et al. 2014. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity 40: 40-50.
23. Fahim, M., C. M. Hawley, S. P. McDonald, F. G. Brown, J. B. Rosman, K. J. Wiggins, K. M. Bannister, and D. W. Johnson. 2010. Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases. Nephrol. Dial. Transplant. 25: 3386-3392.
24. Govindarajulu, S., C. M. Hawley, S. P. McDonald, F. G. Brown, J. B. Rosman, K. J.Wiggins, K. M. Bannister, and D.W. Johnson. 2010. Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit. Dial. Int. 30: 311-319.
25. López-Cabrera, M. 2014. Mesenchymal conversion of mesothelial cells is a key event in the pathophysiology of the peritoneum during peritoneal dialysis. Adv. Med. 2014: 473134.
26. Frencher, J. T., H. Shen, L. Yan, J. O. Wilson, N. E. Freitag, A. N. Rizzo, C. Y. Chen, and Z. W. Chen. 2014. HMBPP-deficient Listeria mutant immunization alters pulmonary/systemic responses, effector functions, and memory polarization of Vg2Vd2 T cells. J. Leukoc. Biol. 96: 957-967.
27. Workalemahu, G., H. Wang, K. J. Puan, M. H. Nada, T. Kuzuyama, B. D. Jones, C. Jin, and C. T. Morita. 2014. Metabolic engineering of Salmonella vaccine bacteria to boost human Vg2Vd2 T cell immunity. J. Immunol. 193: 708-721.
28. Chen, Z., H. Wang, C. D'Souza, S. Sun, L. Kostenko, S. B. Eckle, B. S. Meehan, D. C. Jackson, R. A. Strugnell, H. Cao, et al. 2016. Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals. Mucosal Immunol. doi:10.1038/ mi.2016.39.
29. Brown, M. C., K. Simpson, J. J. Kerssens, and R. A. Mactier, Scottish Renal Registry. 2011. Peritoneal dialysis-associated peritonitis rates and outcomes in a national cohort are not improving in the post-millennium (2000-2007). Perit. Dial. Int. 31: 639-650.
30. Piraino, B., J. Bernardini, E. Brown, A. Figueiredo, D. W. Johnson, W. C. Lye, V. Price, S. Ramalakshmi, and C. C. Szeto. 2011. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit. Dial. Int. 31: 614-630.
31. Montamat-Sicotte, D. J., K. A. Millington, C. R. Willcox, S. Hingley-Wilson, S. Hackforth, J. Innes, O. M. Kon, D. A. Lammas, D. E. Minnikin, G. S. Besra, et al. 2011. A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection. J. Clin. Invest. 121: 2493-2503.
32. Kasmar, A. G., I. van Rhijn, T. Y. Cheng, M. Turner, C. Seshadri, A. Schiefner, R. C. Kalathur, J. W. Annand, A. de Jong, J. Shires, et al. 2011. CD1b tetramers bind ab T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans. J. Exp. Med. 208: 1741-1747.
33. Hintz, M., A. Reichenberg, B. Altincicek, U. Bahr, R. M. Gschwind, A. K. Kollas, E. Beck, J. Wiesner, M. Eberl, and H. Jomaa. 2001. Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gammadelta T cells in Escherichia coli. FEBS Lett. 509: 317-322.
34. Corbett, A. J., S. B. Eckle, R. W. Birkinshaw, L. Liu, O. Patel, J. Mahony, Z. Chen, R. Reantragoon, B. Meehan, H. Cao, et al. 2014. T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature 509: 361-365.
35. Grimaldi, D., L. Le Bourhis, B. Sauneuf, A. Dechartres, C. Rousseau, F. Ouaaz, M. Milder, D. Louis, J. D. Chiche, J. P. Mira, et al. 2014. Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med. 40: 192-201.
36. Eberl, M., I. M. Friberg, A. R. Liuzzi, M. P. Morgan, and N. Topley. 2014. Pathogen-specific immune fingerprints during acute infection: the diagnostic potential of human gd T-cells. Front. Immunol. 5: 572.
37. Lambie, M., J. Chess, K. L. Donovan, Y. L. Kim, J. Y. Do, H. B. Lee, H. Noh, P. F. Williams, A. J. Williams, S. Davison, et al. 2013. Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival. J. Am. Soc. Nephrol. 24: 2071-2080.
38. Rodrigues-Díez, R., L. S. Aroeira, M. Orejudo, M. A. Bajo, J. J. Heffernan, R. R. Rodrigues-Díez, S. Rayego-Mateos, A. Ortiz, G. Gonzalez-Mateo, M. López-Cabrera, et al. 2014. IL-17A is a novel player in dialysis-induced peritoneal damage. Kidney Int. 86: 303-315.
39. Lambie, M. R., J. Chess, A. M. Summers, P. F. Williams, N. Topley, and S. J. Davies, GLOBAL Fluid Study Investigators. 2016. Peritoneal inflammation precedes encapsulating peritoneal sclerosis: results from the GLOBAL fluid study. Nephrol. Dial. Transplant. 31: 480-486.
40. Huang, S., S. Gilfillan, M. Cella, M. J. Miley, O. Lantz, L. Lybarger, D. H. Fremont, and T. H. Hansen. 2005. Evidence for MR1 antigen presentation to mucosal-associated invariant T cells. J. Biol. Chem. 280: 21183-21193.
41. Harly, C., Y. Guillaume, S. Nedellec, C. M. Peigné, H. Mönkkönen, J. Mönkkönen, J. Li, J. Kuball, E. J. Adams, S. Netzer, et al. 2012. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human gd T-cell subset. Blood 120: 2269-2279.
42. Jomaa, H., J. Wiesner, S. Sanderbrand, B. Altincicek, C. Weidemeyer, M. Hintz, I. Türbachova, M. Eberl, J. Zeidler, H. K. Lichtenthaler, et al. 1999. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 285: 1573-1576.
43. Zhao, Y., A. Bacher, B. Illarionov, M. Fischer, G. Georg, Q. Z. Ye, P. E. Fanwick, S. G. Franzblau, B. Wan, and M. Cushman. 2009. Discovery and development of the covalent hydrates of trifluoromethylated pyrazoles as riboflavin synthase inhibitors with antibiotic activity against Mycobacterium tuberculosis. J. Org. Chem. 74: 5297-5303.
44. Davey, M. S., J. M. Tyrrell, R. A. Howe, T. R. Walsh, B. Moser, M. A. Toleman, and M. Eberl. 2011. A promising target for treatment of multidrug-resistant bacterial infections. Antimicrob. Agents Chemother. 55: 3635-3636.
45. Haase, I., T. Gräwert, B. Illarionov, A. Bacher, and M. Fischer. 2014. Recent advances in riboflavin biosynthesis. Methods Mol. Biol. 1146: 15-40.